几天前，一项来自中国生物技术公司的自研抗体开发技术平台再获海外专利授权，再次点燃了“硬科技出海”的关注热度。 2025年6月5日，百奥赛图宣布，其自主研发的RenMab®全人抗体小鼠平台，获得了由日本专利局（JPO）颁发的发明专利证书。这不仅是对其技术创新能力的高度认可，也标志着中国Biotech企业在全球知识产权竞争中迈出的又一坚实步伐。 而这并非孤例。近年来，越来越多以技术为核心驱动的中国Bi ...

US biotech major Regeneron identifies site for its GCC to be operational in 2nd half of 2026 in Hyderabad: Our Bureau, ...

In the world of biotechnology investing, companies often struggle to bring new drugs to market. Developing treatments for rare diseases can be incredibly expensive, and because these conditions affect ...

Biotechnology is the application of biological organisms, cells, or molecules to produce a product or service for the betterment of humankind. This area of study includes aspects of molecular biology, ...

Discover the role of biotechnology in healthcare, medicine, and investment. Understand biotech processes, top companies, and ...

Franklin Pierce University has announced it will offer a Bachelor of Science in Biotechnology beginning in Fall 2026, to align with its popular Health Science and other STEM-based undergraduate ...

WASHINGTON, DC (ANI) – U.S. lawmakers and industry leaders are intensifying calls for stricter export controls to prevent American biopharmaceutical companies from collaborating with China military on ...